Hjem › Kreft (alle typer) › New York › Buffalo
Kliniske studier for Kreft (alle typer) i Buffalo, NY
19 studier for Kreft (alle typer) søker deltakere på steder i og rundt Buffalo (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekruttererFase 1
- Roswell Park Cancer Institute, Buffalo
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 4, Buffalo
Intratumoral N17350 in Advanced Solid Tumors
RekruttererFase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
RekruttererObservasjonsstudie
- Roswell Park Comprehensive Cancer Center, Buffalo
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- Roswell Park Cancer Institute, Buffalo
Collection of Tissue Samples for Cancer Research
RekruttererObservasjonsstudie
- Roswell Park Cancer Institute, Buffalo
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- Roswell Park Center Institute, Buffalo
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Roswell Park Cancer Institute, Buffalo
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
RekruttererFase 1
- Roswell Park Cancer Institute, Buffalo
Childhood Cancer Survivor Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Roswell Park Cancer Institute, Buffalo
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekruttererFase 1
- Roswell Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RekruttererFase 1
- Roswell Park, Buffalo
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
Rekrutterer
- University at Buffalo / Great Lakes Cancer Care, Buffalo
Cannabis Use and Outcomes in Black and White Patients With Cancer
RekruttererObservasjonsstudie
- University at Buffalo, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Buffalo
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Roswell Park Cancer Institute, Buffalo
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- Roswell Park Cancer Institute, Buffalo
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
Andre studier i Buffalo
- Ikke-småcellet lungekreft19 studier
- Akut myelogen leukemi19 studier
- Lungekreft16 studier
- Brystkreft16 studier
- Eggstokkreft13 studier
- Metastatisk kreft11 studier
- Prostatakreft11 studier
- Melanom10 studier
- Multipelt myelom10 studier
- Fedme9 studier
- Burkitts lymfom8 studier
- Myelodysplastiske syndromer8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.